Detalhe da pesquisa
1.
Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.
Mov Disord
; 39(2): 433-438, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140767
2.
Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis.
Mov Disord
; 37(5): 1028-1039, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35165920
3.
Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 91(6): 631-637, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381639
4.
Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
Brain
; 142(7): 2023-2036, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31056699
5.
Outcome of cell suspension allografts in a patient with Huntington's disease.
Ann Neurol
; 84(6): 950-956, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30286516
6.
Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease.
Mov Disord
; 34(10): 1505-1515, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158314
7.
Role of Mycobacterium avium lysate INF-γ, IL-17, and IL-2 ELISPOT assays in diagnosing nontuberculous mycobacteria lymphadenitis in children.
Eur J Clin Microbiol Infect Dis
; 38(6): 1113-1122, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30834995
8.
Brain Imaging and Impulse Control Disorders in Parkinson's Disease.
Curr Neurol Neurosci Rep
; 19(9): 67, 2019 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396719
9.
Systematic review shows that immunising internationally adopted children is a major challenge for primary health care.
Acta Paediatr
; 108(3): 411-418, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30368909
10.
11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.
Mov Disord
; 33(1): 117-127, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29082547
11.
Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients.
Mov Disord
; 32(2): 235-240, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27859651
12.
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.
Mov Disord
; 32(2): 181-192, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28150432
13.
Restorative Strategies in Movement Disorders: the Contribution of Imaging.
Curr Neurol Neurosci Rep
; 17(12): 98, 2017 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29094222
14.
Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.
Brain
; 139(Pt 8): 2224-34, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27297241
15.
Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.
Neurol Sci
; 38(12): 2095-2101, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28866787
16.
Neuromelanin in parkinsonian disorders: an update.
Int J Neurosci
; 127(12): 1116-1123, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28460588
17.
Aberrant nigral diffusion in Parkinson's disease: A longitudinal diffusion tensor imaging study.
Mov Disord
; 31(7): 1020-6, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27104232
18.
Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
Brain
; 138(Pt 1): 110-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25416179
19.
Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
Brain
; 138(Pt 10): 3003-15, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26210536
20.
Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
Brain
; 138(Pt 10): 3016-29, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26198591